Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 480-070-0 | CAS number: 85-27-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-05-10 to 2004-05-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study well documented, meets generally accepted scientific principles, acceptable for assessment Deviations from the OECD 429 guideline: - animals were not individually housed - according to the guideline OECD 429 (2002), positive controls are used to demonstrate appropriate performance of the assay and competency of the laboratory to successfully conduct the assay. The positive control should produce a positive LLNA response at an exposure level expected to give an increase in the stimulation index (SI) > 3 over the negative control group. Furthermore, testing with the positive controls may be appropriate at intervals of no greater than 6 months. In this study only a differentiation index was given and no stimulation index. For this reason, the performance of this assay can not be assessed. In addition, the stated reliability check was 8 months old. Lastly, it was not stated if a vehicle was used and which concentrations were applied during the reliability check. - a range finding study for the selection of the test concentration was missing, but the test concetration were selected according to a skin irritation test (please refer to "Cross-reference to other study" below). Other guideline: - the individual LN cell count was done manually using Trypan blue exclusion using a NEUBAUER-chamber. Normally, the LN cell count is done by conductometry.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 2004-04-24
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Principles of method if other than guideline:
- The test was performed in accordance with the the following method according to:
- Vohr, H._W. et al. (2000): An intra-laboratory validation of the integrated Model for Differentiation of Skin Reactions (IMDS): discrimination between (Photo)allergic and (photo)irritant skin reactions in mice. Arch Toxicol 73: 501 - 509.
-Homey, B. von Schilling, C., Blümel, J., Schuppe, H.-C., Ruzicka T., Ahr, H.J., Lehmann, P., Vohr, H.-W. (1998): An Integrated Model for the Differentiaiton of Chemical-Induced Allergic and Irritant Skin Reactions. Toxicology and Applied Pharmacology 153: 83 - 94.
- Vohr, H.-W., Homey, B., Schuppe, H.-C., Kind, P. (1994). Detection of photoreactivity demonstrated in a modified local lymph node assay in mice. Photodermatol Photoimmunol Photomed 10: 57 - 64.
The average LN cell count as feature for the activation of the immune system (local lymph nodes) is used for the calculation of a proliferation stimulation index compared with the negative control:
Index = LN cell count (test group)/LN cell count (negative control)
A lymph node index of 1.25 was determined as positive threshold value for the mouse strain NMRI by Vohr et al. The index is to fix at 1.00 if this threshold value is not come up or passed.
The ear swelling being the difference between the average ear thickness of the test and control animals on day 3 is calculated as feature for the skin inflammation at the site of topical treatment:
ear swelling = ear thickness on day 3 (test group) - ear thickness on day 3 (negative control)
An ear thickness increase of at least 0.02 mm was determined as positive threshold value by VOHR et al. The ear swelling is to fix at 0.01 mm if this threshold value is not come up or passed. - GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2003-06-04
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- -
- EC Number:
- 480-070-0
- EC Name:
- -
- Cas Number:
- 85-27-8
- Molecular formula:
- C14H14O2
- IUPAC Name:
- 4-(1-phenylethyl)benzene-1,3-diol
- Details on test material:
- - Name of test material: BIO 377
- Chemical name: 1,3-Benzenediol, 4-(1-phenylethyl)-
- Physical state: clear, viscous to solid
- Storage condition of test material: cool, dry, dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS - SPF albino mice of the strain Shoe:NMRI
- Source: DIMED Schönewalde GmbH, D-16352 Schönwalde
- Age at study initiation: about 9 weeks old
- Weight at study initiation: body weight ranging from 29 g to 42 g
- Housing: the mice were kept in groups in transparent polycarbonate cages (macrolone type III, floor area 810 cm^2) with five animals in each cage. The cages were cleaned and the bedding changed at least twice a week. Bedding was pinewood sawdust "Lignocel-Fasern" from Altromin, D-32791 lage, Lippe.
- Diet (ad libitum): a pelleted complete rodent diet "Altromin 1314" from Altromin GmbH, D-32791 Lage, Lippe
- Water (ad libitum): domestic quality drinking water acidified with hydrochloric acid to pH 2.5 in order to prevent microbial growth
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS - animal room provided with filtered air
- Temperature: 21 °C +/- 3°C
- Relative humidity: 55 % +/- 15 %
- Air changes: 10 times/hour
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 1%, 2.5 % and 5 % (w/w)
- No. of animals per dose:
- 5 female mice
(Note: in the negative control group 5 female mice were used, but means were later calculated for 4 animals because one mouse showed a markedly loss of weight during the study and was excluded from the evaluation) - Details on study design:
- TESTING PROCEDURE:
On day 0 the animals were weighed, the thickness of ears was measured by using a micrometer (Oditest S0247) and an amount of 25 µL of the test item or vehicle respectively was applied topically on the dorsal side of the ears.
The open exposure procedure was repeated on day 1 and 2 with the different concentrations of the test item or with the vehicle.
On day 3 the mice were weighed again and the thickness of ears was measured. Subsequently the animals were killed by inhalation of CO2 and a dissection with removal of the auricular lymph node was carried out. Furthermore circular tissue pieces with a diameter of 7 mm were punched from the ears of the animals in order to determine their weight. The lymph node pairs were also weighed and LN cell suspensions were prepared by mechanical tissue disruption.
The cell counts per millilitre of these suspensions were determined manually by Trypan blue exclusion using a NEUBAUER-chamber.
RELIABILITY CHECK
Control tests with positive reference substances are performed in order to verify the experimental technique.
The last study was carried out between September 2nd, 2003 and September 5th, 2003.
ASSESSMENT
A Differentiation Index (DI) is calculated from the different parameters of investigation which describes the relation between the activation of the local skin-draining lymph nodes and the skin inflammation at the site of topical treatment as well as serves to distinguish between inflammatory (non-specific) and allergic (specific) reaction:
0 < DI < 1 inflammation
DI > 1 allergic reaction
- The average LN cell count as feature for the activation of the immune system (local lymph nodes) is used for the calculation of a proliferation stimulation index compared with the negative control:
Index = LN cell count (test group)/LN cell count (negative control)
A lymph node index of 1.25 was determined as positive threshold value for the mouse strain NMRI by Vohr et al. The index is to fix at 1.00 if this threshold value is not come up or passed.
Based on the fixing of a maximal LN cell counts index being 5 it is possible to calculate a percentage of the dfined maximal index:
% max. LN cell counts index = (stimulation index X 100 %)/5
- The ear swelling being the difference between the average ear thickness of the test and control animals on day 3 is calculated as feature for the skin inflammation at the site of topical treatment:
ear swelling = ear thickness on day 3 (test group) - ear thickness on day 3 (negative control)
An ear thickness oncrease of at least 0.02 mm was determined as positive threshold value by VOHR et al. The ear swelling is to fix at 0.01 mm if this threshold value is not come up or passed.
Based on the fixing of a maximal ear swelling being 0.15 mm it is possible to calculate a percentage of the defined maximal ear swelling:
% max. ear swelling = (ear swelling X 100 %)/0.15 mm
- The quotient from the two percentages comes to the Differentiation Index (DI):
DI = % max. LN cell count index/ % max.ear swelling - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Please refer to "details on study design"
Results and discussion
- Positive control results:
- A Differentiation Index of 2.28 was calculated and a specific (sensitizing) stimulation potential was demonstrated for the undiluted test item α-HEXYLCINNAMALDEHYDE, Lot 13102MO.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The average LN cell count as feature for the activation of the immune system (local lymph nodes) is used for the calculation of a proliferation stimulation index compared with the negative control: Index = LN cell count (test group)/LN cell count (negative control) A lymph node index of 1.25 was determined as positive threshold value for the mouse strain NMRI by Vohr et al. The index is to fix at 1.00 if this threshold value is not come up or passed. The ear swelling being the difference between the average ear thickness of the test and control animals on day 3 is calculated as feature for the skin inflammation at the site of topical treatment: ear swelling = ear thickness on day 3 (test group) - ear thickness on day 3 (negative control) An ear thickness increase of at least 0.02 mm was determined as positive threshold value by VOHR et al. The ear swelling is to fix at 0.01 mm if this threshold value is not come up or passed. Lymph node index: 5 % w/w: SI: 0.95 (LN cell count; 2 pieces) 2.5 % w/w: SI: 1.11 (LN cell count; 2 pieces) 1 % w/w: SI: 0.97 (LN cell count; 2 pieces) Ear swelling - mean(Day 3) [x 0.01]mm: 5 % w/w: 20.4 mm 2.5 % w/w: 21.1 mm 1 % w/w: 19.6 Negative control: 19.8 mm (mean was calculated for 4 animals because one mouse showed a markedly loss of weight during the study and was excluded from the evaluation)
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Not applicable
Any other information on results incl. tables
During the study a remarkable loss of weight was revealed in one animal of the negative control group and caused the exclusion of this animal from the study evaluation of its data.
The remaining nineteen animals showed a normal body weight gain with and without an increase in weight. Only the two test groups with the highest test concentrations showed an ear swelling compared with the negative control but did not exceed the positive threshold value. On day 3 a slight decrease of ear thickness was observed at the test group with the lowest test concentration. The weight determination of ear tissue showed a slight increase at the test groups in comparison to the negative control. This trend towards an increase at the test groups was confirmed for the weights of lymph node pairs. The lymph node cell count of the middle test group was a little above the negative control level. The other two test groups showed lower cell counts compared to the negative control.
Since in all cases the treatment with the test item did not lead to an exceeding of the positive threshold values for both the ear swelling and the lymph node cell count a specific or non-specific stimulation potential can be excluded for the tested concentrations of the test item.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to the EC-Commission directive 67/548/EEC and its subsequent amendments, the test substance is not a skin sensitizer.
According to the EC-Regulation 1272/2008 and subsequent regulations, the test item is is not a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
